Found: 24
Select item for more details and to access through your institution.
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4427, doi. 10.1007/s00277-024-05942-2
- By:
- Publication type:
- Article
Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae405
- By:
- Publication type:
- Article
Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
- Published in:
- Nature Medicine, 2008, v. 14, n. 1, p. 93, doi. 10.1038/nm1695
- By:
- Publication type:
- Article
Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 169, doi. 10.1111/bjh.17840
- By:
- Publication type:
- Article
<i>brca2</i> and <i>tp53</i> Collaborate in Tumorigenesis in Zebrafish.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087177
- By:
- Publication type:
- Article
Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.
- Published in:
- Oncogene, 2002, v. 21, n. 1, p. 148, doi. 10.1038/sj.onc.1204998
- By:
- Publication type:
- Article
Long-Term Follow-up of Foamy Viral Vector-Mediated Gene Therapy for Canine Leukocyte Adhesion Deficiency.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 5, p. 964, doi. 10.1038/mt.2013.34
- By:
- Publication type:
- Article
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 7, p. 1580, doi. 10.1007/s10875-022-01280-y
- By:
- Publication type:
- Article
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
- Published in:
- Journal of Clinical Immunology, 2021, v. 41, n. 7, p. 1633, doi. 10.1007/s10875-021-01098-0
- By:
- Publication type:
- Article
Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.
- Published in:
- Journal of Clinical Immunology, 2017, v. 37, n. 1, p. 61, doi. 10.1007/s10875-016-0360-8
- By:
- Publication type:
- Article
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 1, p. 41, doi. 10.1093/cid/ciw160
- By:
- Publication type:
- Article
Incomplete splicing, cell division defects, and hematopoietic blockage in dhx8 mutant zebrafish.
- Published in:
- Developmental Dynamics, 2012, v. 241, n. 5, p. 879, doi. 10.1002/dvdy.23774
- By:
- Publication type:
- Article
miR‐181c regulates MCL1 and cell survival in GATA2 deficient cells.
- Published in:
- Journal of Leukocyte Biology, 2022, v. 111, n. 4, p. 805, doi. 10.1002/JLB.2A1220-824R
- By:
- Publication type:
- Article
Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28865
- By:
- Publication type:
- Article
Oocyte cryopreservation for women with GATA2 deficiency.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2018, v. 35, n. 7, p. 1201, doi. 10.1007/s10815-018-1146-0
- By:
- Publication type:
- Article
Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 2, p. 119, doi. 10.1002/gcc.20725
- By:
- Publication type:
- Article
Gene Therapy of Canine Leukocyte Adhesion Deficiency Using Lentiviral Vectors With Human CD11b and CD18 Promoters Driving Canine CD18 Expression.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 113, doi. 10.1038/mt.2010.203
- By:
- Publication type:
- Article
662. Retroviral Insertion Site Analysis Following Therapeutic Gene Transfer of CD18 in a Canine Model of Leukocyte Adhesion Deficiency.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S255, doi. 10.1016/j.ymthe.2006.08.739
- By:
- Publication type:
- Article
458. Reversal of Canine Leukocyte Adhesion Deficiency by Retroviral-Vector Mediated Gene Therapy with Non-Myeloablative Conditioning
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 3, p. 332, doi. 10.1002/jcph.1049
- By:
- Publication type:
- Article
Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1445711
- By:
- Publication type:
- Article
Melanoma in patients with GATA2 deficiency.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 2, p. 337, doi. 10.1111/pcmr.12671
- By:
- Publication type:
- Article
GATA2 Deficiency: Early identification for improved clinical outcomes.
- Published in:
- Clinical Journal of Oncology Nursing, 2019, v. 23, n. 4, p. 417, doi. 10.1188/19.CJON.417-422
- By:
- Publication type:
- Article